Xencor, Inc. (XNCR)
22.85
-1.15
(-4.79%)
USD |
NASDAQ |
Oct 16, 16:00
22.87
+0.02
(+0.09%)
After-Hours: 20:00
Xencor Net Income (TTM) : -163.32M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -163.32M |
| March 31, 2026 | -172.42M |
| December 31, 2025 | -92.14M |
| September 30, 2025 | -131.68M |
| June 30, 2025 | -171.95M |
| March 31, 2025 | -208.54M |
| December 31, 2024 | -228.61M |
| September 30, 2024 | -201.68M |
| June 30, 2024 | -179.65M |
| March 31, 2024 | -134.20M |
| December 31, 2023 | -126.25M |
| September 30, 2023 | -119.03M |
| June 30, 2023 | -127.52M |
| March 31, 2023 | -139.54M |
| December 31, 2022 | -55.18M |
| September 30, 2022 | 29.92M |
| June 30, 2022 | 22.49M |
| March 31, 2022 | 108.71M |
| December 31, 2021 | 82.63M |
| September 30, 2021 | -4.121M |
| June 30, 2021 | 23.52M |
| March 31, 2021 | -63.75M |
| December 31, 2020 | -69.33M |
| September 30, 2020 | -82.55M |
| June 30, 2020 | -80.23M |
| Date | Value |
|---|---|
| March 31, 2020 | -61.24M |
| December 31, 2019 | 26.88M |
| September 30, 2019 | 35.59M |
| June 30, 2019 | 48.96M |
| March 31, 2019 | 39.13M |
| December 31, 2018 | -70.41M |
| September 30, 2018 | -44.85M |
| June 30, 2018 | -70.65M |
| March 31, 2018 | -52.50M |
| December 31, 2017 | -38.49M |
| September 30, 2017 | -54.92M |
| June 30, 2017 | -40.34M |
| March 31, 2017 | 14.55M |
| December 31, 2016 | 23.62M |
| September 30, 2016 | 40.45M |
| June 30, 2016 | 38.49M |
| March 31, 2016 | -17.55M |
| December 31, 2015 | -17.59M |
| September 30, 2015 | -26.70M |
| June 30, 2015 | -22.94M |
| March 31, 2015 | -19.12M |
| December 31, 2014 | -16.42M |
| September 30, 2014 | -18.78M |
| June 30, 2014 | -14.33M |
| March 31, 2014 | -12.40M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| UroGen Pharma Ltd. | -97.64M |
| MeiraGTx Holdings Plc | 78.93M |
| IDEAYA Biosciences, Inc. | -175.02M |
| Iovance Biotherapeutics, Inc. | -289.52M |